In hepatocellular carcinoma, miR-125b has an inhibitory effect on EMT and EMT-related features through SMAD2 and SMAD4, which are signal transducers of the TGFβ signaling pathway [58]. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.